Creative Planning Moderna, Inc. Transaction History

Creative Planning

$116 Billion
Q2 2025

A detailed history of Creative Planning transactions in Moderna, Inc. stock. As of the latest transaction made, Creative Planning holds 107,593 shares of MRNA stock, worth $2.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,593

Previous 90,074 19.45%

Holding current value

$2.76 Million

Previous $2.55 Million 16.26%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$23.65 - $28.54 $414,324 - $499,992	17,519 Added 19.45%	107,593 $2.97 Million
Q1 2025 May 15, 2025	SELL	$28.35 - $47.53 $36,968 - $61,979	-1,304 Reduced 1.43%	90,074 $2.55 Million
Q4 2024 Feb 14, 2025	BUY	$36.85 - $63.93 $1.69 Million - $2.94 Million	45,957 Added 101.18%	91,378 $3.8 Million
Q3 2024 Oct 11, 2024	SELL	$63.64 - $125.14 $546,922 - $1.08 Million	-8,594 Reduced 15.91%	45,421 $3.04 Million
Q2 2024 Aug 15, 2024	SELL	$101.21 - $166.61 $297,962 - $490,499	-2,944 Reduced 5.17%	54,015 $6.41 Million
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $751,597 - $1.02 Million	8,804 Added 18.28%	56,959 $6.07 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $2.09 Million - $3.13 Million	-30,017 Reduced 38.4%	48,155 $4.79 Million
Q3 2023 Nov 16, 2023	BUY	$96.41 - $126.61 $3.77 Million - $4.95 Million	39,072 Added 99.93%	78,172 $8.07 Million
Q2 2023 Jul 21, 2023	SELL	$118.5 - $160.53 $625,087 - $846,795	-5,275 Reduced 11.89%	39,100 $4.75 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $772,583 - $1.12 Million	-5,695 Reduced 11.37%	44,375 $6.82 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $688,498 - $1.22 Million	-5,816 Reduced 10.41%	50,070 $8.99 Million
Q3 2022 Nov 03, 2022	SELL	$118.07 - $194.18 $366,489 - $602,734	-3,104 Reduced 5.26%	55,886 $6.61 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $949,104 - $1.43 Million	8,103 Added 15.92%	58,990 $8.43 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $2.04 Million - $3.79 Million	16,104 Added 46.3%	50,887 $8.77 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $16,484 - $26,901	73 Added 0.21%	34,783 $8.83 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $4.13 Million - $9.01 Million	18,593 Added 115.36%	34,710 $13.4 Million
Q2 2021 Aug 04, 2021	SELL	$129.91 - $234.98 $4.67 Million - $8.44 Million	-35,923 Reduced 69.03%	16,117 $3.79 Million
Q1 2021 Apr 30, 2021	SELL	$109.18 - $185.98 $575,815 - $980,858	-5,274 Reduced 9.2%	52,040 $6.82 Million
Q4 2020 Jan 29, 2021	BUY	$65.74 - $169.86 $630,841 - $1.63 Million	9,596 Added 20.11%	57,314 $5.99 Million
Q3 2020 Nov 05, 2020	BUY	$54.34 - $94.85 $63,849 - $111,448	1,175 Added 2.52%	47,718 $3.38 Million
Q2 2020 Jul 23, 2020	SELL	$29.67 - $80.0 $54,978 - $148,240	-1,853 Reduced 3.83%	46,543 $2.99 Million
Q1 2020 May 05, 2020	BUY	$17.78 - $31.58 $860,480 - $1.53 Million	48,396 New	48,396 $1.45 Million

Others Institutions Holding MRNA

# of Institutions

848

Shares Held

258M

Call Options Held

22.4M

Put Options Held

30.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Moderna, Inc. Transaction History